135 related articles for article (PubMed ID: 10988268)
1. Beta-adrenoceptor dysfunction after inhibition of NO synthesis.
Whalen EJ; Johnson AK; Lewis SJ
Hypertension; 2000 Sep; 36(3):376-82. PubMed ID: 10988268
[TBL] [Abstract][Full Text] [Related]
2. Rapid tachyphylaxis to hemodynamic effects of PACAP-27 after inhibition of nitric oxide synthesis.
Whalen EJ; Travis MD; Johnson AK; Lewis SJ
Am J Physiol; 1999 Jun; 276(6 Pt 2):H2117-26. PubMed ID: 10362695
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
4. The influence of chronic inhibition of nitric oxide synthesis on contractile and relaxant properties of rat carotid and mesenteric arteries.
Heijenbrok FJ; Mathy MJ; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):504-11. PubMed ID: 11138842
[TBL] [Abstract][Full Text] [Related]
5. Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
Travis MD; Hoque A; Bates JN; Lewis SJ
Eur J Pharmacol; 2000 Nov; 408(3):289-98. PubMed ID: 11090646
[TBL] [Abstract][Full Text] [Related]
6. Heterologous desensitization of beta-adrenoceptor signal transduction in vivo.
Travis MD; Whalen EJ; Lewis SJ
Eur J Pharmacol; 1997 Jun; 328(1):R1-3. PubMed ID: 9203576
[TBL] [Abstract][Full Text] [Related]
7. Flavin adenine dinucleotide may release preformed stores of nitrosyl factors from the vascular endothelium of conscious rats.
Hashmi-Hill MP; Sandock K; Bates JN; Robertson TP; Lewis SJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):142-54. PubMed ID: 17703130
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors.
Davisson RL; Shaffer RA; Johnson AK; Lewis SJ
Neuroscience; 1996 Jun; 72(4):881-7. PubMed ID: 8735216
[TBL] [Abstract][Full Text] [Related]
9. Tachyphylaxis to PACAP-27 after inhibition of NO synthesis: a loss of adenylate cyclase activation.
Whalen EJ; Johnson AK; Lewis SJ
Am J Physiol; 1999 Nov; 277(5 Pt 2):R1453-61. PubMed ID: 10564219
[TBL] [Abstract][Full Text] [Related]
10. Use-dependent loss of active sympathetic neurogenic vasodilation after nitric oxide synthase inhibition in conscious rats. Evidence for the presence of preformed stores of nitric oxide-containing factors.
Davisson RL; Shaffer RA; Johnson AK; Lewis SJ
Hypertension; 1996 Sep; 28(3):347-53. PubMed ID: 8794815
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide (NO) primarily accounts for endothelium-dependent component of beta-adrenoceptor-activated smooth muscle relaxation of mouse aorta in response to isoprenaline.
Akimoto Y; Horinouchi T; Shibano M; Matsushita M; Yamashita Y; Okamoto T; Yamaki F; Tanaka Y; Koike K
J Smooth Muscle Res; 2002 Oct; 38(4-5):87-99. PubMed ID: 12596888
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
Toyoshima H; Nasa Y; Hashizume Y; Koseki Y; Isayama Y; Kohsaka Y; Yamada T; Takeo S
J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production.
Isenović E; Walsh MF; Muniyappa R; Bard M; Diglio CA; Sowers JR
Metabolism; 2002 Mar; 51(3):380-6. PubMed ID: 11887178
[TBL] [Abstract][Full Text] [Related]
14. Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo.
Hoque A; Bates JN; Lewis SJ
Eur J Pharmacol; 2000 Nov; 408(2):195-8. PubMed ID: 11080526
[TBL] [Abstract][Full Text] [Related]
15. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation.
Strunk V; Hahnenkamp K; Schneuing M; Fischer LG; Rich GF
Anesth Analg; 2001 Mar; 92(3):681-7. PubMed ID: 11226101
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite.
Graves JE; Bates JN; Kooy NW; Lewis SJ
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1137-41. PubMed ID: 16445582
[TBL] [Abstract][Full Text] [Related]
17. Use-dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells.
Davisson RL; Bates JN; Johnson AK; Lewis SJ
Hypertension; 1996 Sep; 28(3):354-60. PubMed ID: 8794816
[TBL] [Abstract][Full Text] [Related]
18. Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta.
Kang KB; van der Zypp A; Majewski H
Clin Exp Pharmacol Physiol; 2007; 34(1-2):95-101. PubMed ID: 17201742
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence that L-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature.
Hoque A; Bates JN; Lewis SJ
Eur J Pharmacol; 1999 Nov; 384(2-3):169-72. PubMed ID: 10611438
[TBL] [Abstract][Full Text] [Related]
20. Peroxynitrite elicits dysfunction of stereoselective s-nitrosocysteine recognition sites.
Lewis SJ; Graves JE; Bates JN; Kooy NW
J Cardiovasc Pharmacol; 2005 Nov; 46(5):637-45. PubMed ID: 16220071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
